PL367340A1 - Quinoline derivatives and use thereof as antitumor agents - Google Patents

Quinoline derivatives and use thereof as antitumor agents

Info

Publication number
PL367340A1
PL367340A1 PL02367340A PL36734002A PL367340A1 PL 367340 A1 PL367340 A1 PL 367340A1 PL 02367340 A PL02367340 A PL 02367340A PL 36734002 A PL36734002 A PL 36734002A PL 367340 A1 PL367340 A1 PL 367340A1
Authority
PL
Poland
Prior art keywords
formula
compound
antitumor agents
quinoline derivatives
salt
Prior art date
Application number
PL02367340A
Other languages
English (en)
Polish (pl)
Inventor
Jerome P. Horwitz
Stewart T. Hazeldine
Thomas H. Corbett
Lisa Polin
Original Assignee
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne State University filed Critical Wayne State University
Publication of PL367340A1 publication Critical patent/PL367340A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
PL02367340A 2001-07-31 2002-07-31 Quinoline derivatives and use thereof as antitumor agents PL367340A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30914401P 2001-07-31 2001-07-31

Publications (1)

Publication Number Publication Date
PL367340A1 true PL367340A1 (en) 2005-02-21

Family

ID=23196886

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02367340A PL367340A1 (en) 2001-07-31 2002-07-31 Quinoline derivatives and use thereof as antitumor agents

Country Status (22)

Country Link
US (3) US6867219B2 (enExample)
EP (1) EP1412332B1 (enExample)
JP (1) JP4310185B2 (enExample)
KR (1) KR20040055774A (enExample)
AT (1) ATE287397T1 (enExample)
AU (1) AU2002355747B2 (enExample)
CA (1) CA2456173A1 (enExample)
DE (1) DE60202682T2 (enExample)
DK (1) DK1412332T3 (enExample)
EA (1) EA007205B1 (enExample)
ES (1) ES2236548T3 (enExample)
GE (1) GEP20063754B (enExample)
HU (1) HUP0401562A2 (enExample)
IL (2) IL160082A0 (enExample)
MX (1) MXPA04000968A (enExample)
NO (1) NO326463B1 (enExample)
NZ (1) NZ530806A (enExample)
PL (1) PL367340A1 (enExample)
PT (1) PT1412332E (enExample)
UA (1) UA75691C2 (enExample)
WO (1) WO2003011832A1 (enExample)
ZA (1) ZA200401185B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001245353A1 (en) * 2000-02-29 2001-09-12 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
PL367340A1 (en) * 2001-07-31 2005-02-21 Wayne State University Quinoline derivatives and use thereof as antitumor agents
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
WO2004024149A1 (de) * 2002-08-24 2004-03-25 Zentaris Gmbh Arzneimittel enthaltend disorale und ihre derivate und deren anwendung zur behandlung gutartiger und bosärtiger tumorerkrankungen
US20070054938A1 (en) * 2005-09-07 2007-03-08 Horwitz Jerome P Antitumor agents
US7470788B2 (en) * 2005-09-07 2008-12-30 Wayne State University Antitumor agents
US8183379B2 (en) * 2005-09-07 2012-05-22 Wayne State University Antitumor agents
EP1897542A1 (en) * 2006-09-07 2008-03-12 Sanofi-Aventis Aqueous formulation comprising an antitumor agent
JO2685B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
WO2009002955A1 (en) * 2007-06-27 2008-12-31 Sanofi-Aventis U.S. Llc Process for the preparation of (2r)-2-[4-(7-bromo-2-quinolyloxy)phenoxy]propanoic acid
US8809562B2 (en) 2011-06-06 2014-08-19 Chevron Phillips Chemical Company Lp Use of metallocene compounds for cancer treatment
WO2024132001A1 (en) * 2022-12-21 2024-06-27 Charles University, Faculty Of Pharmacy In Hradec Kralove Multitarget nuclear receptor ligands based on 2-(4-(quinolin-2-yloxy)phenoxy)propanoic acid and 2-(4-(quinoxalin-2-yloxy)phenoxy)propanoic acid for the treatment of metabolic and liver diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033389B2 (ja) 1979-02-22 1985-08-02 日産化学工業株式会社 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤
US5364831A (en) 1980-08-06 1994-11-15 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US6197728B1 (en) 1980-08-06 2001-03-06 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US5250690A (en) * 1985-05-02 1993-10-05 Dowelanco Haloalkoxy anilide derivatives of 2-4(-heterocyclic oxyphenoxy)alkanoic or alkenoic acids and their use as herbicides
PL367340A1 (en) * 2001-07-31 2005-02-21 Wayne State University Quinoline derivatives and use thereof as antitumor agents
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
US7470788B2 (en) * 2005-09-07 2008-12-30 Wayne State University Antitumor agents

Also Published As

Publication number Publication date
HUP0401562A2 (hu) 2004-12-28
NZ530806A (en) 2006-05-26
UA75691C2 (en) 2006-05-15
US7507749B2 (en) 2009-03-24
NO326463B1 (no) 2008-12-08
IL160082A (en) 2009-06-15
EA200400219A1 (ru) 2004-12-30
DK1412332T3 (da) 2005-05-30
EP1412332A1 (en) 2004-04-28
AU2002355747B2 (en) 2007-12-20
JP2004538314A (ja) 2004-12-24
IL160082A0 (en) 2004-06-20
ZA200401185B (en) 2004-10-21
US20070232643A1 (en) 2007-10-04
US20050159447A1 (en) 2005-07-21
CA2456173A1 (en) 2003-02-13
EA007205B1 (ru) 2006-08-25
US20030144321A1 (en) 2003-07-31
KR20040055774A (ko) 2004-06-26
JP4310185B2 (ja) 2009-08-05
GEP20063754B (en) 2006-02-27
NO20040382L (no) 2004-03-26
US7241894B2 (en) 2007-07-10
PT1412332E (pt) 2005-06-30
DE60202682T2 (de) 2005-12-29
ES2236548T3 (es) 2005-07-16
DE60202682D1 (de) 2005-02-24
EP1412332B1 (en) 2005-01-19
US6867219B2 (en) 2005-03-15
ATE287397T1 (de) 2005-02-15
WO2003011832A1 (en) 2003-02-13
MXPA04000968A (es) 2005-02-17

Similar Documents

Publication Publication Date Title
AP2001002241A0 (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents.
MXPA03005464A (es) Agentes antivirales.
DK1539700T3 (da) 8-hydroxyquinolin-derivater
GB9914486D0 (en) Medicaments
TNSN06032A1 (en) Pyridazine derivatives and their use as therapeutic agents
MY138352A (en) Benzothiazole derivatives
TW200638935A (en) Pyridazine derivatives and their use as therapeutic agents
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
WO2001064645A3 (en) Derivatives of quinoline as alpha-2 antagonists
BRPI0409959A (pt) uso de derivados de azetidinacarboxamida em terapia
IL160082A0 (en) Quinoline derivatives and use thereof as antitumor agents
MX2007004740A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica.
SG145570A1 (en) 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
SE0102440D0 (sv) New compound
ATE390923T1 (de) Topoisomerase-giftmittel
ATE424200T1 (de) Solubilisierte topoisomerase-gift-mittel
TW200606164A (en) New compounds
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
TNSN08093A1 (en) Quinoline derivatives and use as antitumor agents
SE9900190D0 (sv) New compounds
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
EE200200660A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
HK1112915A (en) Quinoline derivatives and use as antitumor agents
TW200744596A (en) Antitumor agents
DE60022047D1 (de) Antivirale therapie

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)